An international study led by Hospital Clínic of Barcelona improves the treatment of liver cancer
A new drug combination extends by 46% the time that liver cancer remains stable, according to an international clinical trial ...
The Lancet14h
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...